Progress in Treatment of Respiratory Infectious Diseases with Chinese Medicine Injection Recommended in Diagnosis and Treatment Protocol for Coronavirus Disease-2019
10.13422/j.cnki.syfjx.20201301
- VernacularTitle:《新型冠状病毒肺炎诊疗方案》 推荐的中药注射剂治疗呼吸系统感染性疾病的研究进展
- Author:
Su-yan LIU
1
;
Lian-mei WANG
1
;
Yong ZHAO
1
;
Chun-ying LI
1
;
Ai-hua LIANG
1
Author Information
1. Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences， Beijing 100700, China
- Publication Type:Research Article
- Keywords:
coronavirus disease-2019;
Chinese medicine injection;
respiratory system;
infection;
application
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2020;26(12):1-13
- CountryChina
- Language:Chinese
-
Abstract:
Coronavirus disease-2019 (COVID-19) is an infectious disease caused by 2019 new coronavirus (2019-nCoV) infection. The disease is highly contagious and people are generally susceptible to it. New coronavirus pneumonia is mainly transmitted by respiratory droplets and close contact, but there is also a possibility of aerosol infection. At present, the outbreak of new coronavirus pneumonia has spread rapidly to all parts of the world. However, there is still no specific drug in clinical treatment. After the outbreak, the National Health Commission organized relevant experts to launch a series of diagnosis and treatment programs, including traditional Chinese medicine（TCM） treatment programs from the Trial Version 3. Chinese medicine injections were applied from the Trial Version 4. In this paper, the applications of Chinese medicine injections, which were recommended in the Trial Version 7 of Diagnosis and Treatment Protocol for COVID-19, in respiratory infectious diseases were summarized. Besides, the potential roles of Chinese medicine injections in the treatment of new coronavirus pneumonia were discussed, in order to provide theoretical basis for the reasonable application of Chinese medicine injection in COVID-19 treatment.
